Skip to main content

Table 2 The proportion of patients who were dispensed an opioid analgesic

From: Too much or too little opioids to patients receiving opioid agonist therapy in Norway (2013–2017): a prospective cohort study

Year 2013 2014 2015 2016 2017
Opioid analgesics No. (%*) No. (%*) No. (%*) No. (%*) No. (%*)
Number of patients 7544 7763 7820 7690 7585
Strong opioid analgesics
 Oxycodone 234 (3) 226 (3) 205 (3) 231 (3) 246 (3)
 Morphine 184 (2) 143 (2) 120 (2) 134 (2) 149 (2)
 Fentanyl 79 (1) 58 (1) 39 (0) 11 (0) 34 (0)
 Buprenophine (non OAT) 129 (2) 138 (2) 154 (2) 163 (2) 145 (2)
 Ketobemidone 51 (1) 55 (1) 48 (1) 49 (1) 31 (0)
 Pethidine 6 (0) 6 (0) 5 (0) <  5 (0) 5 (0)
 Hydromorphone 12 (0) 5 (0) <  5 (0) <  5 (0) <  5 (0)
Weak opioid analgesics
 Codeine 822 (11) 799 (10) 781 (10) 730 (9) 690 (9)
 Tramadol 392 (5) 397 (5) 398 (5) 375 (5) 417 (5)
 Tapentadol 14 (0) 7 (0) 6 (0) 10 (0) 10 (0)
  1. The table displays the proportion of patients on OAT who were dispensed a weak and a strong opioid analgesics in the period 2013–2017. We only included opioid analgesics that had marketing authorization in Norway in the study period
  2. No.: Number of patients, OAT Opioid agonist therapy
  3. * Percent of patients who were dispensed an OAT opioid